Category Archives: Global

The Decline of Clinical Trials in Central and Eastern Europe

Currently, 66% of clinical trials are conducted in North America, Western Europe and Australia.  The U.S. hosts 49% of clinical trial sites and generates approximately 40% of clinical data.  Other regions have arisen in recent years.  The main reasons behind this globalization trend are the availability of highly skilled professionals in new research markets, lower […]
Also posted in Emerging Markets, Europe, R&D | Tagged , , , , , | Leave a comment

Focusing On the Metrics That Matter: A Quick Guide to Marketing Analytics

The medicines business is all about data. Drug discovery relies on the meticulous interpretation of experimental results; clinical trials involve carefully analysing streams of information relating to patient response; even physician decision-making around the most appropriate therapies is becoming more and more data driven. There is no question, data is big on the science side […]
Also posted in E-Media, Europe, Marketing, multimedia, Technology | Tagged , , | Leave a comment

Key Clinical Trial Themes from DIA 2014

The Drug Information Association (DIA), one of the largest non-profit organizations supporting clinical research and drug development, held its 2014 annual meeting in San Diego last week. Applied Clinical Trials’ Moe Alsumidaie looks at three of the key themes from this year’s meeting: incorporating advocacy groups and patient voices in clinical research, breakthrough research applications, and […]
Also posted in Events, Guest Blog, Meetings, R&D, Technology | Tagged , , , , , | Leave a comment

The Rx Firm Tax Exodus: Is Something Wrong with the U.S. System?

As I read the latest reports of yet another big US Rx firm, this time AbbVie, trying to pull off a “tax inversion” takeover of the Irish-based Shire, I couldn’t help but wonder, what the heck is going on here? Right now, it feels like most major US corporations, especially pharmas, are literally running away […]
Also posted in Deals, Europe, Guest Blog, Legal, Op-Ed, Strategy | Tagged , , , , , , | Leave a comment

Q&A: Gauging Impact of Comparative Effectiveness Research

While at DIA’s 50th Annual Meeting, we got the chance to speak with Nancy Dreyer, chief of scientific affairs and senior VP at Quintiles Outcome, the CRO’s real-world and late-phase research division, about the current tide for comparative effectiveness research (CER). Dreyer is the leader of the GRACE Initiative, which has developed good practice principles for […]
Also posted in comparative effectiveness, healthcare, Regulatory, Uncategorized | Tagged , , , , , | Leave a comment
  • Categories

  • Meta